Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study). Rheumatology and Therapy. 2022; 9(2)DOI:10.1007/s40744-021-00423-8. PMID:35041155. IF:3.800(Q3/6D).

Marquès M., Correig E., Ibarretxe D., Anoro E., Antonio Arroyo J., Jericó C., Borrallo R.M., Miret M., Näf S., Pardo A., Perea V., Pérez-Bernalte R., Ramírez-Montesinos R., Royuela M., Soler C., Urquizu-Padilla M., Zamora A., Pedro-Botet J., Masana L., Domingo J.L.. Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality. ENVIRONMENT INTERNATIONAL. 2022; 158DOI:10.1016/j.envint.2021.106930. PMID:34678637. IF:11.800(Q1/1D).

Osuna-Gómez, R, Castellví, I, Mulet, M, Tandaipan, JL, Zamora, C, Codes-Mendez, H, Ortiz, MA, Diaz-Torné, C, Cantó, E, Magallares, B, Guinart-Cuadra, A, Moya, P, Corominas, H, Vidal, S. Platelet bound B cells and their role in SSc: Implications for disease subtypes and clinical outcomes. Translational Research. 2025; 282DOI:10.1016/j.trsl.2025.07.001. PMID:40645372. IF:5.900(Q1/1D).

de Agustin, JJ, Añez, GA, Reina, D, Heredia, S, Ramirez, J, Cuervo, AM, Rodriguez, J, Moragues, C, Moya, P, Alonso, AML, Moreno, M, Arevalo, M, Pujol, M, Salvador, G, Busquets, N, Ponce, A, Pastor, MP. Usefulness of ultrasound in the assessment of the efficacy of apremilast in psoriatic arthritis: Articular, enthesitic and nail index. Reumatologia Clinica. 2025; 21(7)DOI:10.1016/j.reuma.2025.501921. PMID:. IF:(Q/D).

Zhang, YL, Tedeschi, SK, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, JA, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, Diaz-Torne, C, Mccarthy, GM, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Coronel, L, Stamp, LK, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, Fitzgerald, J, Dalbeth, N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 72DOI:10.1016/j.semarthrit.2025.152669. PMID:40086154. IF:4.400(Q1/1D).

Martinez-Molina, C, Park, HS, Díaz-Torné, C, Vidal, S, Corominas, H. FACTORS ASSOCIATED WITH ACHIEVING REMISSION OR LOW DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING JANUS KINASE INHIBITOR TREATMENT. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3700. PMID:. IF:20.600(Q1/1D).

Azuaga, AB, Cuervo, A, Reina, D, Estrada, P, Soria, LM, Aparicio, M, Moreno, M, Arevalo, M, Laiz, A, Moya, P, Alascio, L, Riera, J, Scher, JU, Crespillo, JDDC, Ramirez, J. CLINICAL AND ULTRASOUND FEATURES OF A COHORT OF PSO PATIENTS WITHOUT MUSCULOSKELETAL SYMPTOMS: A PROSPECTIVE AND MULTICENTER STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1990. PMID:. IF:20.600(Q1/1D).

Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellví, I, Alvarez, ED. EVALUATION OF THE NEW CRITERIA FOR PROGRESSIVE PULMONARY FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1643. PMID:. IF:20.600(Q1/1D).

Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellvi, I, Alvarez, ED. COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1597. PMID:. IF:20.600(Q1/1D).

Valera-Ribera, C, Alegre-Sancho, JJ, Castellvi, I, Ibanez, M, Garcia, FJN. DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3437. PMID:. IF:20.600(Q1/1D).

Paños, HB, Saborit, MC, Lasanta, MAL, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernardez, J, Guillen, AG, Aguilar, JR, Cuervo, A, Roc, MV, Gomez, CG, Mínguez, S, Novell, RM, Estrada, P, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gómez-Puerta, JA, Pérez, SH, Palau, NM, Sanmarti, R, Mateo, L, Diaz-Torne, C, Corominas, H, Alarcon, GS. UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3117. PMID:. IF:20.600(Q1/1D).

Avilés, A, Plaza, Z, Sánchez-Alonso, F, Castañeda, S, Fernández-Gutiérrez, B, Diaz-Torne, C, Pilar, FU, González, OM, Gallego, JMS, Giner, E, Cid, AR, Gómez, AP, Nievas, GS, García, J, Juanatey, CG, Llorca, J, González-Gay, MA, Andrés, M. PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.A1239. PMID:. IF:20.600(Q1/1D).

López-Gutiérrez, F, Loricera, J, Tofade, T, Prieto-Peña, D, Romero-Yuste, S, De Miguel, E, Riveros-Frutos, A, Nuñez, DF, Ferraz-Amaro, I, Castañeda, S, Labrador-Sánchez, E, Maiz, O, Garcia, FJN, Galindez-Agirregoikoa, E, González, I, Urruticoechea-Arana, A, Calvo, AR, Moya, P, Unizony, S, Blanco, R. EFFECTIVENESS AND SAFETY OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2775. PMID:. IF:20.600(Q1/1D).

Sanmarti, R, Perez-Garcia, C, de-Toro-Santos, FJ, Alarcon, GS, Escudero-Contreras, A, Cuervo, A, Graell, E, Reina, D, Binstock, EK, Corominas, H, Urionaguena-Onaindia, I, Lasanta, MAL, Alejandro, O, Gomez, MS, Frade-Sosa, B, Novell, RM, Polino, L, Ostiz, JAM, Oreiro, N, Blanco, FJ, Nadales, IP, Ortega-Castro, R, Busquets-Pérez, N, Gómez-Centeno, A, Camacho, O, Cros, JRR, Arciniegas, AMM, Llorente, JFG, Paños, HB, Prior-Español, A, Quiñones, SC, Cruceta, A, Bonfill, E, Gómez, GD, Fàbregas, AR, Maestre, LT, Gomara, MJ, Haro, I. EFFECTS OF ABATACEPT VERSUS HYDROXYCHLOROQUINE ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PALINDROMIC RHEUMATISM: ATWO-YEAR MULTICENTER RANDOMIZED CLINICAL TRIAL. THE PALABA STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B938. PMID:. IF:20.600(Q1/1D).

López-Gutiérrez, F, Loricera, J, Calabuig, PM, Gil, JJF, González-Mazario, R, Hormigos, C, Freites, D, Laguna, MR, Moya, P, Gómez, ML, Corominas, H, Silva-Díaz, M, Arribas, GG, García-Aparicio, A, Font, J, Casafont-Solé, I, Castaneda, E, Argumánez, CM, Zas, R, Molina-Collada, J, Montero, SR, Melero-González, RB, Galindez-Agirregoikoa, E, Hernández, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, Mena-Vázquez, N, Gallego, A, Cabaleiro-Raña, N, González, RV, Andrés, M, Castañeda, S. CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3669. PMID:. IF:20.600(Q1/1D).

De Miguel, E, Dominguez-Alvaro, M, Hernández-Rodríguez, I, Silva-Díaz, M, Otano, JMB, Moya, P, Cabañas, MT, Angeles, VAN, Calvet, J, Casafont-Solé, I, Ivorra, JAR, Labrada-Arrabal, S, Vasques-Rocha, M, Iñiguez, CL, Dorta, AG, Fernández, CC, Villar, MA, Mas, AJ, Prado, FJ, Blanco, R. ACR/EULAR 2022 CLASSIFICATION CRITERIA COMPARED TO THE ACR 1990 CLASSIFICATION CRITERIA IN THE ARTESER REGISTRY OF GIANT CELL ARTERITIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B849. PMID:. IF:20.600(Q1/1D).

García-Escudero, P, López-Gómez, M, López, BM, Dorta, AG, Frade-Sosa, B, Lizarzaburu, MS, Rúa-Figueroa, I, Fiallo, DV, de Miera, FJTS, Melero-Gonzalez, RB, Santos, DD, Miranda, JA, Belando, CG, Boselli, G, Boteanu, AL, Villalobos, L, Selaya, CC, Santos, CS, Alvarez, ED, Font, J, Alonso, ER, Araguás, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, Gómez, IV, Vela-Casasempere, P, Merino, C, Martínez, MI, Beriain, JAH, Ruiz-Román, A, Calvo-Alén, J. VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort. RHEUMATOLOGY. 2025; 64(6)DOI:10.1093/rheumatology/keaf094. PMID:39937690. IF:4.400(Q1/1D).

Bjorkekjar, HJ, Bruni, C, Broch, K, Brunborg, C, Delgado, PC, Airo, P, Simeon-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, C, Gabrielli, A, Del Galdo, F, Vonk, M, Fretheim, H, Bitter, H, Midtvedt, O, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Mueller-Ladner, U, Matucci-Cerinic, M, Castellvi, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1890. PMID:. IF:20.600(Q1/1D).

Lopez, BPM, Lopez-Corbeto, M, Zavala, RG, Torrent, RB, Gonzalez-Fernandez, MI, Perello, CM, Sevilla-Perez, B, Fontana, NP, Pascual, AR, Ildefonso, MMS, Regueira, SM, Alcaniz, P, Gonzalez, JCN, Grana, J. TRANSITION IN BONE METABOLISM: INSIGHTS FROM A NATIONAL SURVEY IN SPAIN. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1745. PMID:. IF:20.600(Q1/1D).

Lasanta, MAL, Saborit, MC, Panos, HB, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernarde, J, Guillen, AG, Aguilar, JR, Cuervo, A, Valls, M, Gomez, CG, Minguez, S, Novell, RM, Alarcon, PE, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gomez-Puerta, JA, Perez, SH, Palau, NM, Sanmarti, R, Mateo-Soria, L, Diaz-Torne, C, Coromina, H, Alarcon, GS. COMPARISON OF BARICITINIB AND TOFACITINIB EFFECTIVENESS IN RHEUMATOID ARTHRITIS: INSIGHTS FROM A REAL-WORLD COHORT USING PROPENSITY SCORE ADJUSTMENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2477. PMID:. IF:20.600(Q1/1D).